Effect of Irrigation Pressure on Postoperative Complications and Surgical Field Clarity in Unilateral Biportal Endoscopic Surgery
1 other identifier
interventional
80
1 country
1
Brief Summary
This study is being done to find out if the height of the fluid bag and the direction of the surgical cut affect the pressure of the fluid used during unilateral biportal endoscopic (UBE) spine surgery. UBE is a minimally invasive surgery for the spine. During this surgery, fluid is used to keep the surgical area clear and to control bleeding. The pressure of this fluid may affect how clear the surgical view is, how much bleeding occurs, and how well patients recover after surgery. We will also collect disc tissue removed during surgery to study how disc degeneration is related to factors such as sex, age, mechanical stress, and injury. About 80 patients aged 18 to 75 who are scheduled for UBE surgery at our hospital will take part. Patients will be randomly assigned to one of four groups based on two things: the height of the fluid bag (0.9 meters or 1.0 meters) and the direction of the surgical cut (horizontal or vertical). We will measure the fluid pressure around the spinal covering during surgery and record how clear the surgical view is. After surgery, we will track patients' pain and recovery for at least 6 months. This study has been approved by the hospital ethics committee.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 5, 2026
CompletedFirst Submitted
Initial submission to the registry
September 18, 2026
CompletedFirst Posted
Study publicly available on registry
September 23, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2028
September 23, 2026
September 1, 2026
1.8 years
September 18, 2026
September 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Irrigation pressure around the dura
Intraoperative irrigation pressure around the dura measured continuously during UBE surgery.
During surgery
Study Arms (4)
0.9 m Fluid Bag Height + Transverse Incision
EXPERIMENTALUBE surgery with 0.9 m fluid bag height and transverse incision.
0.9 m Fluid Bag Height + Longitudinal Incision
EXPERIMENTALUBE surgery with 0.9 m fluid bag height and longitudinal incision.
1.0 m Fluid Bag Height + Transverse Incision
EXPERIMENTALUBE surgery with 1.0 m fluid bag height and transverse incision.
1.0 m Fluid Bag Height + Longitudinal Incision
EXPERIMENTALUBE surgery with 1.0 m fluid bag height and longitudinal incision.
Interventions
UBE surgery performed with specified fluid bag height (0.9 m or 1.0 m) and incision direction (transverse or longitudinal).
Eligibility Criteria
You may qualify if:
- Age \>= 18 years and \< 75 years.
- Patients scheduled for unilateral biportal endoscopic (UBE) surgery for lumbar degenerative disease at the First Affiliated Hospital of Kunming Medical University between February 2026 and December 2027.
- Follow-up duration \> 6 months.
- Complete clinical and follow-up data available.
- Voluntary participation and signed informed consent.
You may not qualify if:
- History of tuberculosis, infection, tumor, or trauma.
- Severe cardiac, hepatic, or renal insufficiency.
- History of chronic lung disease, liver disease, HIV infection, diabetes, or renal insufficiency.
- Psychiatric disorders or inability to comply with follow-up.
- Severe osteoporosis.
- Pregnant or lactating women.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fan Zhanglead
- National Natural Science Foundation of Chinacollaborator
Study Sites (1)
The First Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, 650032, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- The First Affiliated Hospital of Kunming Medical University
Study Record Dates
First Submitted
September 18, 2026
First Posted
September 23, 2026
Study Start
February 5, 2026
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
January 1, 2028
Last Updated
September 23, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared because the study involves a small sample of patients from a single center, and the data contain sensitive personal and surgical information. Protecting participant privacy and complying with local ethics regulations are the primary reasons for not sharing the data.